Business of Medicine

Opinion

Time to rebuild

While adhering to guidance that suggests we treat obesity as a disease, we should also look at and seek to...

News

FDA withdraws approval of Makena

The medication was approved in 2011 to reduce the risk for preterm birth, but a postmarketing study did not show clinical benefit.

Pages